• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,25(OH)2 维生素 D3 在 DSS 诱导的小鼠急性结肠炎中对黏膜损伤和上皮屏障破坏的保护作用。

Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.

机构信息

Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, No,215 Heping West Road, 050000, Shijiazhuang, China.

出版信息

BMC Gastroenterol. 2012 May 30;12:57. doi: 10.1186/1471-230X-12-57.

DOI:10.1186/1471-230X-12-57
PMID:22647055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3464614/
Abstract

BACKGROUND

Intestinal hyper-permeability plays a critical role in the etiopathogenesis of inflammatory bowel disease (IBD) by affecting the penetration of pathogens, toxic compounds and macromolecules. 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D, has been shown to be an important regulator of IBD and recent epidemiology suggests that patients with IBD have an impaired vitamin D status. The purpose of this study is to investigate the possible protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier disruption on dextran sulfate sodium (DSS)-induced acute colitis model.

METHODS

We used DSS-induced acute colitis model to investigate the protective effects of 1,25(OH)2D3 on mucosal injury and epithelial barrier integrity. Severity of colitis was evaluated by disease activity index (DAI), body weight (BW) change, colon length, histology, myeloperoxidase (MPO) activity, and proinflammatory cytokine production including tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). In vitro the protective role of 1,25(OH)2D3 was assessed by incubating Caco-2 cells with or without DSS and measuring transepithelial electrical resistance (TEER) and fluorescein isothiocyanate dextran (FITC-D). The intestinal permeability was analyzed by FITC-D, bacterial translocation and measurement of lipopolysaccharide (LPS). Ultrastructural features of the colon tissue and Caco-2 cell monolayer were observed by electron microscopy. Expressions of tight junction (TJ) proteins in the colon mucosa and Caco-2 cells were detected by immunohistochemistry, immunofluorescence, Western blot and real-time fluorescent quantitative PCR, respectively.

RESULTS

DSS-induced acute colitis model was characterized by a reduced BW, AUC of BW, serum calcium, higher DAI, AUC of DAI, shortened colon length, elevated MPO activity, worsened histologic inflammation, increased mononuclear cell numbers in mesenteric lymph nodes (MLNs) and colonic lamina propria (LP), and enhanced proteins and mRNA levels of TNF-α and IFN-γ. 1,25(OH)2D3 markedly increased expressions of TJ proteins and mRNA and decreased the FITC-D permeability and the level of LPS. Furthermore, 1,25(OH)2D3 abrogated bacterial translocation to MLNs and ameliorated ultrastructural features of the colon epithelium by scanning electron microscopy (SEM). In vitro, 1,25(OH)2D3 increased TEER, TJ proteins and mRNA expressions, decreased the FITC-D permeability, and preserved structural integrity of the TJ in Caco-2 cells.

CONCLUSIONS

1,25(OH)2D3 may play a protective role in mucosal barrier homeostasis by maintaining the integrity of junction complexes and in healing capacity of the colon epithelium. 1,25(OH)2D3 may represent an attractive and novel therapeutic agent for the adjuvant therapy of IBD.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/3464614/5dfac15c233d/1471-230X-12-57-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/3464614/5dfac15c233d/1471-230X-12-57-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb59/3464614/5dfac15c233d/1471-230X-12-57-3.jpg
摘要

背景

肠道通透性在炎症性肠病(IBD)的发病机制中起着关键作用,通过影响病原体、有毒化合物和大分子的渗透。1,25-二羟维生素 D3[1,25(OH)2D3],维生素 D 的活性形式,已被证明是 IBD 的重要调节剂,最近的流行病学研究表明,IBD 患者存在维生素 D 状态受损。本研究旨在探讨 1,25(OH)2D3 对葡聚糖硫酸钠(DSS)诱导的急性结肠炎模型中粘膜损伤和上皮屏障破坏的可能保护作用。

方法

我们使用 DSS 诱导的急性结肠炎模型来研究 1,25(OH)2D3 对粘膜损伤和上皮屏障完整性的保护作用。通过疾病活动指数(DAI)、体重(BW)变化、结肠长度、组织学、髓过氧化物酶(MPO)活性以及肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)等促炎细胞因子的产生来评估结肠炎的严重程度。在体外,通过用或不用 DSS 孵育 Caco-2 细胞来评估 1,25(OH)2D3 的保护作用,并测量跨上皮电阻(TEER)和荧光素异硫氰酸酯右旋糖(FITC-D)。通过 FITC-D、细菌易位和测量脂多糖(LPS)分析肠道通透性。通过电子显微镜观察结肠组织和 Caco-2 细胞单层的超微结构特征。通过免疫组织化学、免疫荧光、Western blot 和实时荧光定量 PCR 分别检测结肠黏膜和 Caco-2 细胞中紧密连接(TJ)蛋白的表达。

结果

DSS 诱导的急性结肠炎模型的特征是 BW、BW 的 AUC、血清钙降低,DAI、AUC 的 DAI 升高,结肠长度缩短,MPO 活性升高,组织学炎症恶化,肠系膜淋巴结(MLNs)和结肠固有层(LP)中的单核细胞数量增加,TNF-α 和 IFN-γ 的蛋白和 mRNA 水平升高。1,25(OH)2D3 显著增加 TJ 蛋白和 mRNA 的表达,降低 FITC-D 通透性和 LPS 水平。此外,1,25(OH)2D3 可阻止细菌易位至 MLNs,并通过扫描电子显微镜(SEM)改善结肠上皮的超微结构特征。在体外,1,25(OH)2D3 增加 TEER、TJ 蛋白和 mRNA 的表达,降低 FITC-D 的通透性,并保持 Caco-2 细胞中 TJ 的结构完整性。

结论

1,25(OH)2D3 通过维持连接复合物的完整性和结肠上皮的愈合能力,在粘膜屏障稳态中发挥保护作用。1,25(OH)2D3 可能是 IBD 辅助治疗的一种有吸引力的新型治疗药物。

相似文献

1
Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.1,25(OH)2 维生素 D3 在 DSS 诱导的小鼠急性结肠炎中对黏膜损伤和上皮屏障破坏的保护作用。
BMC Gastroenterol. 2012 May 30;12:57. doi: 10.1186/1471-230X-12-57.
2
Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.Toll样受体3激动剂聚肌胞苷酸对急性结肠炎小鼠模型肠黏膜及上皮屏障功能的影响
World J Gastroenterol. 2017 Feb 14;23(6):999-1009. doi: 10.3748/wjg.v23.i6.999.
3
Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.维生素D受体在维持肠道黏膜屏障完整性中的新作用。
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G208-16. doi: 10.1152/ajpgi.00398.2007. Epub 2007 Oct 25.
4
Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.TL1A 表达对 DSS 诱导结肠炎肠黏膜屏障的影响及其机制。
Dig Dis Sci. 2019 Jul;64(7):1844-1856. doi: 10.1007/s10620-019-05580-z. Epub 2019 Apr 4.
5
Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.发酵大麦和大豆(BS)混合物可增强葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠模型的肠道屏障功能。
BMC Complement Altern Med. 2016 Dec 3;16(1):498. doi: 10.1186/s12906-016-1479-0.
6
Porcine β-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis.猪β-防御素2减轻葡聚糖硫酸钠诱导的结肠炎中的炎症和黏膜损伤。
J Immunol. 2015 Feb 15;194(4):1882-93. doi: 10.4049/jimmunol.1402300. Epub 2015 Jan 19.
7
High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.高通量筛选鉴定肠道屏障功能的宿主和微生物群调节剂。
Gastroenterology. 2020 Nov;159(5):1807-1823. doi: 10.1053/j.gastro.2020.07.003. Epub 2020 Jul 9.
8
Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.维生素 D 缺乏使黏附侵袭性大肠埃希菌引起的屏障功能障碍和实验性结肠损伤更容易发生。
Inflamm Bowel Dis. 2015 Feb;21(2):297-306. doi: 10.1097/MIB.0000000000000282.
9
1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation.1,25-二羟基维生素D3通过调节辅助性T细胞(Th)1和Th17的激活来调控慢性结肠炎的发展。
APMIS. 2015 Jun;123(6):490-501. doi: 10.1111/apm.12378. Epub 2015 Apr 23.
10
Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.小檗碱通过改善肠道屏障功能和抑制炎症反应来缓解 DSS 诱导的溃疡性结肠炎。
Eur J Pharmacol. 2021 Apr 5;896:173912. doi: 10.1016/j.ejphar.2021.173912. Epub 2021 Jan 27.

引用本文的文献

1
Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.可溶性唾液酸结合免疫球蛋白样凝集素9改善代谢功能障碍相关脂肪性肝炎小鼠模型的肠道屏障功能。
Metabolites. 2025 May 30;15(6):366. doi: 10.3390/metabo15060366.
2
Disrupted mitochondrial morphology and function exacerbate inflammation in elderly-onset ulcerative colitis.线粒体形态和功能紊乱会加剧老年起病型溃疡性结肠炎中的炎症。
Immun Ageing. 2025 Jan 10;22(1):4. doi: 10.1186/s12979-024-00494-5.
3
Effects of Vitamin D Supplementation on Serum 25-Hydroxy Cholecalciferol in Inflammatory Bowel Diseases: A Meta-Analysis of Randomized Clinical Trials.

本文引用的文献

1
Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium.白细胞介素-6(IL-6)调节肠道上皮细胞中紧密连接蛋白-2 的表达和紧密连接通透性。
J Biol Chem. 2011 Sep 9;286(36):31263-71. doi: 10.1074/jbc.M111.238147. Epub 2011 Jul 19.
2
Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling.在缺乏维生素 D 信号的情况下, converge 途径导致 IL-17 的过度产生。
Int Immunol. 2011 Aug;23(8):519-28. doi: 10.1093/intimm/dxr045. Epub 2011 Jun 22.
3
Immunopathogenesis of inflammatory bowel disease.
补充维生素D对炎症性肠病患者血清25-羟基胆钙化醇的影响:一项随机临床试验的荟萃分析
Int J Prev Med. 2024 Nov 28;15:65. doi: 10.4103/ijpvm.ijpvm_133_23. eCollection 2024.
4
A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.一种改善腹泻型肠易激综合征肠道内稳态的饮食营养新策略:肠道菌群与肠上皮相互作用的新视角。
Nutrients. 2024 Sep 21;16(18):3192. doi: 10.3390/nu16183192.
5
Co-administration of 1,25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation.1,25-二羟基维生素D3与英夫利昔单抗联合给药通过调节调节性T细胞分化改善小鼠结肠炎。
Iran J Basic Med Sci. 2024;27(9):1172-1179. doi: 10.22038/IJBMS.2024.74640.16209.
6
IgA class-switched CD27-CD21+ B cells in IgA nephropathy.IgA肾病中IgA类别转换的CD27-CD21+ B细胞
Nephrol Dial Transplant. 2025 Feb 28;40(3):505-515. doi: 10.1093/ndt/gfae173.
7
Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis.原人参二醇可改善隐窝和黏膜结构,抑制结肠炎富集微生物,并改变免疫反应以减轻结肠炎。
Am J Physiol Gastrointest Liver Physiol. 2024 May 1;326(5):G591-G606. doi: 10.1152/ajpgi.00004.2024. Epub 2024 Mar 12.
8
Taurine Regulates the Expression of Interleukin -17/10 and Intestinal Flora and Protects the Liver and Intestinal Mucosa in a Nonalcoholic Fatty Liver Disease Rat Model.牛磺酸在非酒精性脂肪性肝病大鼠模型中调节白细胞介素-17/10的表达及肠道菌群,并保护肝脏和肠黏膜。
Diabetes Metab Syndr Obes. 2024 Feb 9;17:675-689. doi: 10.2147/DMSO.S440978. eCollection 2024.
9
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells.III 型固有淋巴细胞调节的疾病发病机制和屏障功能。
Semin Immunopathol. 2024 Jan;45(4-6):509-519. doi: 10.1007/s00281-024-01000-1. Epub 2024 Feb 2.
10
Intestinal Membrane Function in Inflammatory Bowel Disease.炎症性肠病中的肠膜功能
Pharmaceutics. 2023 Dec 25;16(1):29. doi: 10.3390/pharmaceutics16010029.
炎症性肠病的免疫发病机制
Self Nonself. 2010 Oct;1(4):299-309. doi: 10.4161/self.1.4.13560.
4
Vitamin D and inflammatory bowel disease.维生素 D 与炎症性肠病。
Vitam Horm. 2011;86:367-77. doi: 10.1016/B978-0-12-386960-9.00016-2.
5
Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2.真菌毒素脱氧雪腐镰刀菌烯醇(DON)介导肠猪上皮细胞系 IPEC-1 和 IPEC-J2 的双相细胞反应。
Toxicol Lett. 2011 Jan 15;200(1-2):8-18. doi: 10.1016/j.toxlet.2010.10.006. Epub 2010 Oct 19.
6
Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.肥大细胞在白细胞介素-10 缺陷型小鼠炎症性肠病和炎症相关结直肠肿瘤中的作用。
PLoS One. 2010 Aug 17;5(8):e12220. doi: 10.1371/journal.pone.0012220.
7
MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function.微小 RNA 控制肠道上皮细胞的分化、结构和屏障功能。
Gastroenterology. 2010 Nov;139(5):1654-64, 1664.e1. doi: 10.1053/j.gastro.2010.07.040. Epub 2010 Jul 24.
8
Vitamin D and mucosal immune function.维生素 D 与黏膜免疫功能。
Curr Opin Gastroenterol. 2010 Nov;26(6):591-5. doi: 10.1097/MOG.0b013e32833d4b9f.
9
Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression.糖原合酶激酶3(GSK-3)通过调节闭合蛋白、紧密连接蛋白-1和E-钙黏蛋白的表达来影响上皮屏障功能。
Biochem Biophys Res Commun. 2010 Jul 2;397(3):592-7. doi: 10.1016/j.bbrc.2010.05.164.
10
Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.过氧化物酶体增殖物激活受体γ2突变可能导致一部分溃疡性结肠炎病例。
Pediatr Int. 2010 Oct;52(5):729-34. doi: 10.1111/j.1442-200X.2010.03195.x.